Neutrophil gelatinase-associated lipocalin as a prognostic biomarker of severe acute respiratory distress syndrome
Association of plasma neutrophil gelatinase-associated lipocalin and thoracic aorta calcification in maintenance hemodialysis patients with and without diabetes, BMC Nephrology
Urine/Plasma Neutrophil Gelatinase Associated Lipocalin Ratio Is a Sensitive and Specific Marker of Subclinical Acute Kidney Injury in Mice
Neutrophil Gelatinase-Associated Lipocalin Measured on Clinical Laboratory Platforms for the Prediction of Acute Kidney Injury and the Associated Need for Dialysis Therapy: A Systematic Review and Meta-analysis - ScienceDirect
Neutrophil Gelatinase-Associated Lipocalin Measured on Clinical Laboratory Platforms for the Prediction of Acute Kidney Injury and the Associated Need for Dialysis Therapy: A Systematic Review and Meta-analysis - ScienceDirect
Delayed Graft Function in the Kidney Transplant - American Journal of Transplantation
Neutrophil gelatinase-associated lipocalin as a biomarker for predicting acute kidney injury after coronary artery bypass grafting, Ain-Shams Journal of Anesthesiology
JCM, Free Full-Text
Antifibrotic effect of novel neutrophil gelatinase-associated lipocalin inhibitors in cardiac and renal disease models
Figure 1 from Neutrophil gelatinase-associated lipocalin (NGAL) as biomarker of acute kidney injury: a review of the laboratory characteristics and clinical evidences
The cardiac surgery–associated neutrophil gelatinase-associated lipocalin ( CSA-NGAL) score: A potential tool to monitor acute tubular damage - ScienceDirect
Oral abstracts - 2022 - Pediatric Transplantation - Wiley Online Library
Series: Renal, Metabolic and Urologic Disorders, BISAC: MED071000, Acute kidney injury (AKI), defined as an abrupt decrease in renal function over a
Neutrophil Gelatinase-Associated Lipocalin: from Laboratory to Clinical Utility
PDF) Plasma Neutrophil Gelatinase-Associated Lipocalin and Worsening Renal Function During Everolimus Therapy After Heart Transplantation
PDF) Adverse renal effects associated with cardiopulmonary bypass